About the company


Extherid Bioscience is a newly formed specialty contract research organization (CRO) based in Jackson, WY that delivers a range of biological R&D services with a focus on infectious diseases. The mission of Extherid is to create innovative solutions for infectious diseases by joining basic molecular concepts to clinical applications. Extherid was created to address the need to develop new approaches to combat the spread of multidrug-resistant organisms. Our proven ability to partner with our clients to discover therapeutic targets and develop technologies with efficacy in the clinical setting is made possible by combining molecular mechanisms of diseases with experimental and clinical pharmacology applications. We have developed approaches, including customizable tissue models, to bridge the gap between the bench (in vitro) to first in human studies (in vivo). We utilize this approach to synthesize information, identify opportunities, and design experimental studies to create new technologies. Management has an established track record of working with a number of partners that include Fortune 100 companies and academic and government entities.

our research

Dr. Marnie Peterson

The company was founded by Dr. Marnie L. Peterson, Pharm.D., Ph.D., an expert in experimental therapeutics, antibiotic resistance, and microbial pathogenesis with 20 years of experience in the development of new therapeutics for infectious diseases. Before establishing Extherid Biosciences (a woman-owned business), Dr. Peterson was tenured faculty at the University of Minnesota, Department of Experimental and Clinical Pharmacology. At the University, she successfully established a research program and was granted over $9 million dollars from the National Institutes of Health, Department of Defense, foundations, and industrial partners. She holds a significant patent portfolio for her discoveries, one of which served as the basis for the establishment of a clinical stage start-up company, Hennepin Life Sciences. She earned a Ph.D. in Infection from the University of Birmingham, Medical School, United Kingdom, and Pharm.D. and B.S. degrees from the University of Minnesota. Additionally, Dr. Peterson recently joined the University of Wyoming faculty as a research professor.

Minnesota Business Magazine 2014 Leaders in Health Care Finalist:

Awarded to an individual who is driving advancements in discovery and innovation through research, delivery of care, or a new procedure.


Our Team

Our multidisciplinary team of talented scientists come from academic and industry settings with backgrounds in microbial pathogenesis, antibiotic resistance, immunology, molecular and cellular biology, clinical pharmacology, bioinformatics, and preclinical and clinical development.


Biomarker ID
Microbial Pathogenesis
Development of Therapeutics

Partner with us